The Vita Coco Company Reports Third Quarter 2026 Financial Results and Raises
The Vita Coco Company Reports Third Quarter 2026 Financial Results and Raises Full Year Guidance
Net Income Increased $11 million to $35 million and Non-GAAP Adjusted EBITDA² Increased $21 million to $53 million
Raises Fiscal Year 2026 Guidance for Net Sales to Between $810 Million and $820 Million and Non-GAAP Adjusted EBITDA² to between $170 million and $175 million
The Vita Coco Company, Inc. (NASDAQ:COCO) (“Vita Coco” or “the Company”), a leading high-growth platform of better-for-you beverage brands, today announced financial results for the third quarter ended September 30, 2026.
• Net sales were $244 million, an increase of $62 million, or 34%, in the third quarter , and $640 million year-to-date, an increase of $158 million, or 33%.
• Vita Coco Coconut Water net sales grew 15% in the third quarter and 24% year- to-date.
• Private Label net sales grew 152% in the third quarter and 85% year-to-date, with the third quarter benefiting from the contribution of Copra, a leading producer of super premium Thai Nam Hom coconut water that was acquired in July 2026.
• Gross profit was $93 million in the third quarter, an increase of $24 million, and $270 million year-to-date, an increase of $92 million.
• Gross margin was 38% of net sales in the third quarter consistent with prior year, and was 42% of net sales year-to-date compared to 37%, with tariff refunds delivering a 240 basis point benefit to gross margin year-to-date.
• Net income was $35 million in the third quarter, compared to $24 million, an increase of $11 million, and $115 million year-to-date, compared to $66 million, an increase of $49 million.
• Net income per diluted share was $0.58 in the third quarter, compared to $0.40, and $1.89 per diluted share year-to-date, compared to $1.10.
• Non-GAAP Adjusted EBITDA² was $53 million in the third quarter, compared to $32 million, an increase of $21 million. Non-GAAP Adjusted EBITDA 2 was $159 million year-to-date, compared to $84 million, an increase of $75 million.
Michael Kirban, the Company's Co-Founder and Executive Chairman, stated, "The growth of the coconut water category maintained through the fall, and remains one of the fastest growing beverage categories in our major markets. I am particularly pleased by the strong growth in Europe as we develop the category in key markets, and the continued growth in America, driven by increases in both household penetration and in average consumption per household. This quarter, we were pleased to welcome the Copra team to our family and to start executing our joint plans, which we believe will allow us to compete successfully in the super premium segment. With the investments we are making in our supply chain, and
our strong brand performance, I am confident in our plans to maintain our growth into 2027, and our category leadership well into the future."
Martin Roper, the Company’s Chief Executive Officer, said, “Our strong third quarter net sales growth was driven by robust branded retail growth in all our major markets, and by strong growth in private label shipments, reflecting healthy category growth and the addition of Copra's super premium products. Excluding the impact of Copra, the underlying 18% organic net sales growth of our business remained very strong, exceeding our expectations. Consumer demand is very healthy, and we are therefore raising our full year Net Sales and Adjusted EBITDA guidance."
Net sales increased $62 million, or 34%, to $244 million for the third quarter ended September 30, 2026, compared to $182 million in the prior year period. The increase in net sales was driven by case equivalent ("CE") volume gains of 16% for Vita Coco Coconut Water and 77% for Private Label. Organic net sales growth 1 , which is net sales growth excluding the impact of Copra, was 18% for the quarter. Copra net sales primarily impacted Private Label, with Copra branded coconut water and commodity net sales recognized in Other.
Gross profit increased to $93 million, from $69 million in the prior year period driven by higher sales volume, the addition of Copra, and minimal tariffs compared to the prior year period, partially offset by higher domestic logistics costs. Gross margin was 38%, in line with the prior year period, benefitting from minimal tariffs compared to the prior year period, offset by higher domestic logistics costs, and the dilutive impact of Copra.
Selling, general and administrative ("SG&A") expenses were $47 million, compared to $41 million in the prior year period. The increase was primarily driven by costs related to the acquisition of Copra, amortization expense associated with intangible assets acquired in the Copra acquisition, higher people-related costs reflecting increased headcount and stock-based compensation, as well as higher sales related expenses.
Net income was $35 million, or $0.58 per diluted share, compared to net income of $24 million, or $0.40 per diluted share, in the prior year period. Net income benefited from higher gross profit, partially offset by higher SG&A spending and increased income tax expense .
Non-GAAP Adjusted EBITDA 2 was $53 million, compared to $32 million in the prior year due to the increased gross profit partially offset by higher SG&A expenses.
As of September 30, 2026, the Company's financial position remained strong with no debt and $152 million in cash and cash equivalents. Cash decreased $45 million from the beginning of the year, and $127 million from end of the second quarter due to net cash used for the acquisition of Copra of $139 million. Our inventory was $111 million, flat to December 31, 2025, with the inclusion of Copra inventory offsetting the inventory draw down from strong year-to-date shipments. Accounts receivable increased to $129 million from $82 million as of prior year end due to strong quarterly sales and the inclusion of Copra.
As of September 30, 2026, the Company had repurchased approximately $86 million of its common stock under its share repurchase program and had $19 million remaining under the existing authorization. During the nine months ended September 30, 2026, the Company repurcha sed $62 million of its common stock. As of October 22, 2026, the Company has repurchased $94 million of its common stock, and had $11 million remaining of the $105 million authorized amount under the repurchase program.
• Net sales expected to be between $810 million and $820 million, driven by low 20s percent growth of Vita Coco Coconut Water, strong Private Label trends and the addition of Copra. (Prior guidance was between $790 million and $805 million, which included the benefit of Copra).
• Gross margin expected to be approximately 40% with benefit relative to prior year from lower tariffs, tariff refunds, and higher pricing partially offset by increased ocean freight, product and other transportation costs, alongside adverse product mix, primarily due to the impact of Copra's private label business and strong
private label trends. (No change from prior guidance). Fourth quarter gross margin expected to be approximately 33% due to increases in cost of goods and no offsetting price actions expected until early 2027.
• Expect to deliver SG&A leverage of approximately 1.5 percentage points of net sales vs. 2025. (Prior guidance was one percentage point).
• Adjusted EBITDA ² expected to be in the range of $170 million to $175 million.
Uncertainty and instability in the current operating environment, geopolitical landscape, and global economies, including the military conflict in Iran and related impacts, changes in tariff rates, natural disasters, associated potential competitive pricing actions, and our own price elasticity could affect this outlook and our future results.
(1) Organic net sales growth is a supplemental measure of net sales performance that excludes the impact of net sales attributable to the Copra acquisition as set forth in the U.S. GAAP to non-GAAP reconciliation table below.
(2) Adjusted EBITDA represents earnings before interest, taxes, depreciation, and amortization as adjusted for certain items as set forth in the reconciliation table of U.S. GAAP to non-GAAP information and is a measure calculated and presented on the basis of methodologies other than in accordance with GAAP. Please refer to the Non-GAAP Financial Measures herein for further discussion and reconciliation of this measure to GAAP measures.
(3) GAAP Net income 2026 outlook is not provided due to the inherent difficulty in quantifying certain amounts due to a variety of factors including the unpredictability in the movement in foreign currency rates, as well as future charges or reversals outside of the normal course of business.
To participate in the live earnings call and question and answer session, please register at https://register-conf.media- server.com/register/BIb7dfca7ed24e41c7a1cd98a3f2cfb4e0 and dial-in information will be provided directly to you. The live audio webcast will be accessible in the “Events” section of the Company’s Investor Relations website at https://investors.thevitacococompany.com . An archived replay of the webcast will be available shortly after the live event has concluded.
The Vita Coco Company is a family of brands on a mission to reimagine what’s possible when brands deliver healthy, nutritious , and great tasting products that are better for consumers and better for the world. This includes its flagship coconut water brand Vita Coco, and Copra, a super-premium brand that specializes in Thai Nam Hom coconut water. The Company was co-founded in 2004 by Michael Kirban and Ira Liran and is a public benefit corporation and Certified B Corporation. Vita Coco, the principal brand within the Company’s portfolio, is the leading coconut water brand in the U.S. With electrolytes and nutrients, coconut water has become a top beverage choice among consumers after a workout, in smoothies, as a cocktail mixer, after a night out and more.
In addition to disclosing results determined in accordance with U.S. GAAP, the Company also discloses certain non-GAAP results of operations, including, but not limited to, Adjusted EBITDA, and organic net sales growth, which include certain adjustments or exclude certain charges and gains that are described in the reconciliation table of U.S. GAAP to non-GAAP information provided at the end of this release. These non-GAAP measures are a key metric used by management and our board of directors to assess our financial performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance and because we believe it is useful for investors to see the measures that management uses to evaluate the Company. In addition, we believe the presentation of these measures is useful to investors for period-to-period comparisons of results as the items described below in the reconciliation tables do not reflect ongoing operating performance.
These measures are not in accordance with, or an alternative to, U.S. GAAP, and may be different from non-GAAP measures used by other companies. In addition, other companies, including companies in our industry, may calculate such measures differently, which reduces their usefulness as a comparative measure. Investors should not rely on any single financial measure when evaluating our business. This information should be considered as supplemental in nature and is not meant as a substitute for our operating results in accordance with U.S. GAAP. We recommend investors review the U.S. GAAP financial measures included in this earnings release. When viewed in conjunction with our U.S. GAAP results and the accompanying reconciliations, we believe these non-GAAP measures provide greater transparency and a more complete understanding of factors affecting our business than U.S. GAAP measures alone.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, statements regarding our future financial and operating performance, including our GAAP and non-GAAP guidance, our strategy, projected costs, tariffs, prospects, expectations, plans, objectives of management, supply chain predictions, customer and supplier relationships, expected impact of acquisitions, and expected net sales and category share growth.
The forward-looking statements in this release are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond the Company’s control. These factors include, but are not limited to, those discussed under the caption “Risk Factors” in our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and our other filings with the U.S. Securities and Exchange Commission ("SEC") as such factors may be updated from time to time and which are accessible on the SEC’s website at www.sec.gov and the Investor Relations page of our website at https://investors.thevitacococompany.com. Any forward-looking statements contained in this press release speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. We disclaim any obligation or undertaking to update or revise any forward-looking statements contained in this press release, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.
We intend to use our websites, vitacoco.com and investors.thevitacococompany.com, as a means for disclosing material non-public information and for complying with the SEC's Regulation FD and other disclosure obligations.
Assets Current assets: September 30,2026 December 31,2025 ────────────────────────────────────────────────────────────────────────────── Cash and cash $ 151,995 $ 196,873 equivalents Accounts receivable, net of allowance of $3,282 at 128,724 81,514 September 30, 2026, and $2,660 at December 31, 2025 Inventory 111,296 111,468 Supplier advances, 339 693 current Derivative 1,794 732 assets Prepaid expenses and other 39,536 30,160 current assets Total current 433,684 421,440 assets Property and 24,441 9,298 equipment, net Goodwill 110,175 7,791 Intangible 107,116 — assets, net Supplier advances, 1,593 1,860 long-term Deferred tax 6,627 6,623 assets, net Right-of-use 10,337 11,592 assets, net Other assets 2,169 2,714 Total assets $ 696,142 $ 461,318 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 46,389 $ 25,464 Accrued expenses and other 126,632 89,461 current liabilities Derivative 2,059 1,507 liabilities Total current 175,080 116,432 liabilities Deferred tax 24,875 160 liability Operating lease liability, 12,119 13,087 long-term Seller's 55,100 — earn-out Other long-term 240 97 liabilities Total $ 267,414 $ 129,776 liabilities Stockholders’ equity: Common stock, $0.01 par value; 500,000,000 shares authorized; 65,396,253 and 64,186,549 shares issued at September 30, 2026 and December 31, 654 642 2025, respectively; 57,202,356 and 57,082,173 shares outstanding at September 30, 2026 and December 31, 2025, respectively. Additional 231,578 185,400 paid-in capital Retained 342,956 228,014 earnings Accumulated other comprehensive -1,050 486 gain (loss) Treasury stock, 8,193,897 shares at cost as of September -145,410 -83,000 30, 2026, and 7,104,376 as of December 31, 2025. Total stockholders’ 428,728 331,542 equity Total liabilities and $ 696,142 $ 461,318 stockholders’ equity
Nine Months Ended Cash flows from September 30, operating activities: 2026 2025 ────────────────────────────────────────────────────────────────────────────── Net income $ 114,942 $ 65,793 Adjustments required to reconcile net income to cash flows from operating activities: Depreciation and 2,458 636 amortization Amortization of debt 14 11 issuance cost Increase of provision 187 1,300 for credit losses Unrealized (gain) on derivative -511 -6,275 instruments Stock-based 11,338 8,123 compensation Impairment loss on — 185 Runa assets Noncash lease expense 1,242 1,052 Changes in operating assets and liabilities: Accounts receivable -42,801 -39,706 Inventory 33,259 -302 Prepaid expenses, net supplier advances, -7,236 345 and other assets Accounts payable, accrued expenses, and 39,050 19,907 other liabilities Net cash provided by operating 151,942 51,069 activities Cash flows from investing activities: Cash paid for property -803 -4,921 and equipment Acquisition of Copra Inc., net of $8,340 -139,253 — cash acquired Net cash used in -140,056 -4,921 investing activities Cash flows from financing activities: Proceeds from exercise 6,131 2,281 of stock awards Cash paid on notes -3 -8 payable Cash paid to acquire -62,410 -10,204 treasury stock Net cash used in -56,282 -7,931 financing activities Effects of exchange rate changes on cash -475 833 and cash equivalents Net (decrease) increase in cash and -44,871 39,050 cash equivalents Cash, cash equivalents and restricted 198,154 165,933 cash at beginning of the period (1) Cash, cash equivalents and restricted $ 153,283 204,983 cash at end of the period (1)
1 Includes $1,281 and $1,264 of restricted cash as of December 31, 2025 and 2024, respectively. Includes $1,288 and $1,278 of restricted cash as of September 30, 2026 and 2025, respectively, reported in other current assets on the condensed consolidated balance sheet.
During the nine months ended September 30, 2026, the Company issued common stock with a fair value of $35,000 and recognized contingent consideration with a fair value of $55,100 in connection with the acquisition of Copra. These transactions are reflected as noncash investing and financing activities.
(a) Non-cash charges related to stock-based compensation, which vary from period to period depending on volume and vesting timing of awards and forfeitures. We adjusted for these charges to facilitate comparison from period to period.
(b) Unrealized gains or losses on derivative instruments and foreign currency gains or losses are not considered in our evaluation of our ongoing performance.
(c) Acquisition-related costs represent transaction, advisory, legal, accounting, valuation, and other professional fees incurred in connection with the acquisition of Copra.
(d) The three and nine months ended September 30, 2025 included $0.6 million and $1.8 million, respectively, related to a one-time incentive program established in 2023 and measured based on full-year 2025 performance, and $0.4 million and $1.1 million, respectively, of overlapping rent expense associated with our new New York City office, and $0.2 million of impairment loss related to the sale of Runa. The three months ended September 30, 2025 also includes $0.1 million of provision for credit losses related to the partially recovered prepaid inventory from a supplier recorded in the first half of 2025 (refer to the Form 10-K and the Form 10-Q for the quarterly period ended June 30, 2025 for further details). The nine month period was partially offset by $0.1 million of partial recoveries of prepaid inventory from a supplier (refer to the Form 10-K for further details) and a $0.2 million gain from a sale of intellectual property.
Note: A CE is a standard volume measure used by management which is defined as a case of 12 bottles of 330ml liquid beverages or the same liter volume of oil. We may have immaterial sales of raw materials at times that are treated as zero CEs for the purposes of these calculations.
Full text with the tables
Exhibit 99.1
The Vita Coco Company Reports Third Quarter 2026 Financial Results and Raises
Full Year Guidance
Net Sales Increased 34% , Driven by Vita Coco Coconut Water Growth of 15%;
Organic Net Sales Growth 1 of 18%
Net Income Increased $11 million to $35 million and Non-GAAP Adjusted EBITDA²
Increased $21 million to $53 million
Raises Fiscal Year 2026 Guidance for Net Sales to Between $810 Million and $820
Million and Non-GAAP Adjusted EBITDA² to between $170 million and $175 million
NEW YORK, NY – October 22, 2026 –
The Vita Coco Company, Inc. (NASDAQ:COCO) (“Vita Coco” or “the Company”), a
leading high-growth platform of better-for-you beverage brands, today announced
financial results for the third quarter ended September 30, 2026.
Third Quarter and Year-to-Date 2026 Highlights Compared to Prior Year Period
• Net sales were $244 million, an increase of $62 million, or 34%, in the third
quarter , and $640 million year-to-date, an increase of $158 million, or 33%.
• Organic net sales growth 1 was 18% in the third quarter and 27% year-to-date.
• Vita Coco Coconut Water net sales grew 15% in the third quarter and 24% year-
to-date.
• Private Label net sales grew 152% in the third quarter and 85% year-to-date,
with the third quarter benefiting from the contribution of Copra, a leading
producer of super premium Thai Nam Hom coconut water that was acquired in July
2026.
• Gross profit was $93 million in the third quarter, an increase of $24 million,
and $270 million year-to-date, an increase of $92 million.
• Gross margin was 38% of net sales in the third quarter consistent with prior
year, and was 42% of net sales year-to-date compared to 37%, with tariff refunds
delivering a 240 basis point benefit to gross margin year-to-date.
• Net income was $35 million in the third quarter, compared to $24 million, an
increase of $11 million, and $115 million year-to-date, compared to $66 million,
an increase of $49 million.
• Net income per diluted share was $0.58 in the third quarter, compared to
$0.40, and $1.89 per diluted share year-to-date, compared to $1.10.
• Non-GAAP Adjusted EBITDA² was $53 million in the third quarter, compared to
$32 million, an increase of $21 million. Non-GAAP Adjusted EBITDA 2 was $159
million year-to-date, compared to $84 million, an increase of $75 million.
Michael Kirban, the Company's Co-Founder and Executive Chairman, stated, "The
growth of the coconut water category maintained through the fall, and remains
one of the fastest growing beverage categories in our major markets. I am
particularly pleased by the strong growth in Europe as we develop the category
in key markets, and the continued growth in America, driven by increases in both
household penetration and in average consumption per household. This quarter, we
were pleased to welcome the Copra team to our family and to start executing our
joint plans, which we believe will allow us to compete successfully in the super
premium segment. With the investments we are making in our supply chain, and
our strong brand performance, I am confident in our plans to maintain our growth
into 2027, and our category leadership well into the future."
Martin Roper, the Company’s Chief Executive Officer, said, “Our strong third
quarter net sales growth was driven by robust branded retail growth in all our
major markets, and by strong growth in private label shipments, reflecting
healthy category growth and the addition of Copra's super premium products.
Excluding the impact of Copra, the underlying 18% organic net sales growth of
our business remained very strong, exceeding our expectations. Consumer demand
is very healthy, and we are therefore raising our full year Net Sales and
Adjusted EBITDA guidance."
Third Quarter 2026 Consolidated Results
Net sales increased $62 million, or 34%, to $244 million for the third quarter
ended September 30, 2026, compared to $182 million in the prior year period. The
increase in net sales was driven by case equivalent ("CE") volume gains of 16%
for Vita Coco Coconut Water and 77% for Private Label. Organic net sales growth
1 , which is net sales growth excluding the impact of Copra, was 18% for the
quarter. Copra net sales primarily impacted Private Label, with Copra branded
coconut water and commodity net sales recognized in Other.
Gross profit increased to $93 million, from $69 million in the prior year period
driven by higher sales volume, the addition of Copra, and minimal tariffs
compared to the prior year period, partially offset by higher domestic logistics
costs. Gross margin was 38%, in line with the prior year period, benefitting
from minimal tariffs compared to the prior year period, offset by higher
domestic logistics costs, and the dilutive impact of Copra.
Selling, general and administrative ("SG&A") expenses were $47 million, compared
to $41 million in the prior year period. The increase was primarily driven by
costs related to the acquisition of Copra, amortization expense associated with
intangible assets acquired in the Copra acquisition, higher people-related costs
reflecting increased headcount and stock-based compensation, as well as higher
sales related expenses.
Net income was $35 million, or $0.58 per diluted share, compared to net income
of $24 million, or $0.40 per diluted share, in the prior year period. Net income
benefited from higher gross profit, partially offset by higher SG&A spending and
increased income tax expense .
Non-GAAP Adjusted EBITDA 2 was $53 million, compared to $32 million in the prior
year due to the increased gross profit partially offset by higher SG&A expenses.
Balance Sheet
As of September 30, 2026, the Company's financial position remained strong with
no debt and $152 million in cash and cash equivalents. Cash decreased $45
million from the beginning of the year, and $127 million from end of the second
quarter due to net cash used for the acquisition of Copra of $139 million. Our
inventory was $111 million, flat to December 31, 2025, with the inclusion of
Copra inventory offsetting the inventory draw down from strong year-to-date
shipments. Accounts receivable increased to $129 million from $82 million as of
prior year end due to strong quarterly sales and the inclusion of Copra.
As of September 30, 2026, the Company had repurchased approximately $86 million
of its common stock under its share repurchase program and had $19 million
remaining under the existing authorization. During the nine months ended
September 30, 2026, the Company repurcha sed $62 million of its common stock. As
of October 22, 2026, the Company has repurchased $94 million of its common
stock, and had $11 million remaining of the $105 million authorized amount under
the repurchase program.
Fiscal Year 2026 Full Year Outlook³
The Company is increasing its full year 2026 guidance, as follows:
• Net sales expected to be between $810 million and $820 million, driven by low
20s percent growth of Vita Coco Coconut Water, strong Private Label trends and
the addition of Copra. (Prior guidance was between $790 million and $805
million, which included the benefit of Copra).
• Gross margin expected to be approximately 40% with benefit relative to prior
year from lower tariffs, tariff refunds, and higher pricing partially offset by
increased ocean freight, product and other transportation costs, alongside
adverse product mix, primarily due to the impact of Copra's private label
business and strong
private label trends. (No change from prior guidance). Fourth quarter gross
margin expected to be approximately 33% due to increases in cost of goods and no
offsetting price actions expected until early 2027.
• Expect to deliver SG&A leverage of approximately 1.5 percentage points of net
sales vs. 2025. (Prior guidance was one percentage point).
• Adjusted EBITDA ² expected to be in the range of $170 million to $175 million.
(Prior guidance was between $154 million and $161 million).
Uncertainty and instability in the current operating environment, geopolitical
landscape, and global economies, including the military conflict in Iran and
related impacts, changes in tariff rates, natural disasters, associated
potential competitive pricing actions, and our own price elasticity could affect
this outlook and our future results.
Footnotes
(1) Organic net sales growth is a supplemental measure of net sales performance
that excludes the impact of net sales attributable to the Copra acquisition as
set forth in the U.S. GAAP to non-GAAP reconciliation table below.
(2) Adjusted EBITDA represents earnings before interest, taxes, depreciation,
and amortization as adjusted for certain items as set forth in the
reconciliation table of U.S. GAAP to non-GAAP information and is a measure
calculated and presented on the basis of methodologies other than in accordance
with GAAP. Please refer to the Non-GAAP Financial Measures herein for further
discussion and reconciliation of this measure to GAAP measures.
(3) GAAP Net income 2026 outlook is not provided due to the inherent difficulty
in quantifying certain amounts due to a variety of factors including the
unpredictability in the movement in foreign currency rates, as well as future
charges or reversals outside of the normal course of business.
Conference Call and Webcast Details
To participate in the live earnings call and question and answer session, please
register at https://register-conf.media-
server.com/register/BIb7dfca7ed24e41c7a1cd98a3f2cfb4e0 and dial-in information
will be provided directly to you. The live audio webcast will be accessible in
the “Events” section of the Company’s Investor Relations website at
https://investors.thevitacococompany.com . An archived replay of the webcast
will be available shortly after the live event has concluded.
About The Vita Coco Company
The Vita Coco Company is a family of brands on a mission to reimagine what’s
possible when brands deliver healthy, nutritious , and great tasting products
that are better for consumers and better for the world. This includes its
flagship coconut water brand Vita Coco, and Copra, a super-premium brand that
specializes in Thai Nam Hom coconut water. The Company was co-founded in 2004 by
Michael Kirban and Ira Liran and is a public benefit corporation and Certified B
Corporation. Vita Coco, the principal brand within the Company’s portfolio, is
the leading coconut water brand in the U.S. With electrolytes and nutrients,
coconut water has become a top beverage choice among consumers after a workout,
in smoothies, as a cocktail mixer, after a night out and more.
Contacts
Investor Relations:
ICR, Inc.
[email protected]
Non-GAAP Financial Measures
In addition to disclosing results determined in accordance with U.S. GAAP, the
Company also discloses certain non-GAAP results of operations, including, but
not limited to, Adjusted EBITDA, and organic net sales growth, which include
certain adjustments or exclude certain charges and gains that are described in
the reconciliation table of U.S. GAAP to non-GAAP information provided at the
end of this release. These non-GAAP measures are a key metric used by management
and our board of directors to assess our financial performance across reporting
periods on a consistent basis by excluding items that we do not believe are
indicative of our core operating performance and because we believe it is useful
for investors to see the measures that management uses to evaluate the Company.
In addition, we believe the presentation of these measures is useful to
investors for period-to-period comparisons of results as the items described
below in the reconciliation tables do not reflect ongoing operating performance.
These measures are not in accordance with, or an alternative to, U.S. GAAP, and
may be different from non-GAAP measures used by other companies. In addition,
other companies, including companies in our industry, may calculate such
measures differently, which reduces their usefulness as a comparative measure.
Investors should not rely on any single financial measure when evaluating our
business. This information should be considered as supplemental in nature and is
not meant as a substitute for our operating results in accordance with U.S.
GAAP. We recommend investors review the U.S. GAAP financial measures included in
this earnings release. When viewed in conjunction with our U.S. GAAP results and
the accompanying reconciliations, we believe these non-GAAP measures provide
greater transparency and a more complete understanding of factors affecting our
business than U.S. GAAP measures alone.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. All statements contained in this
press release that do not relate to matters of historical fact should be
considered forward-looking statements, including, but not limited to, statements
regarding our future financial and operating performance, including our GAAP and
non-GAAP guidance, our strategy, projected costs, tariffs, prospects,
expectations, plans, objectives of management, supply chain predictions,
customer and supplier relationships, expected impact of acquisitions, and
expected net sales and category share growth.
The forward-looking statements in this release are only predictions. We have
based these forward-looking statements largely on our current expectations and
projections about future events and financial trends that we believe may affect
our business, financial condition and results of operations. Forward-looking
statements involve known and unknown risks, uncertainties and other important
factors that may cause our actual results, performance or achievements to be
materially different from any future results, performance or achievements
expressed or implied by the forward-looking statements. Forward-looking
statements involve a number of risks, uncertainties or other factors beyond the
Company’s control. These factors include, but are not limited to, those
discussed under the caption “Risk Factors” in our Annual Reports on Form 10-K,
Quarterly Reports on Form 10-Q and our other filings with the U.S. Securities
and Exchange Commission ("SEC") as such factors may be updated from time to time
and which are accessible on the SEC’s website at www.sec.gov and the Investor
Relations page of our website at https://investors.thevitacococompany.com. Any
forward-looking statements contained in this press release speak only as of the
date hereof and accordingly undue reliance should not be placed on such
statements. We disclaim any obligation or undertaking to update or revise any
forward-looking statements contained in this press release, whether as a result
of new information, future events or otherwise, other than to the extent
required by applicable law.
Website Disclosure
We intend to use our websites, vitacoco.com and
investors.thevitacococompany.com, as a means for disclosing material non-public
information and for complying with the SEC's Regulation FD and other disclosure
obligations.
THE VITA COCO COMPANY, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands, except share data)
Assets
Current assets: September 30,2026 December 31,2025
──────────────────────────────────────────────────────────────────────────────
Cash and cash $ 151,995 $ 196,873
equivalents
Accounts
receivable, net
of allowance of
$3,282 at 128,724 81,514
September 30,
2026, and $2,660
at December 31,
2025
Inventory 111,296 111,468
Supplier
advances, 339 693
current
Derivative 1,794 732
assets
Prepaid expenses
and other 39,536 30,160
current
assets
Total current 433,684 421,440
assets
Property and 24,441 9,298
equipment, net
Goodwill 110,175 7,791
Intangible 107,116 —
assets, net
Supplier
advances, 1,593 1,860
long-term
Deferred tax 6,627 6,623
assets, net
Right-of-use 10,337 11,592
assets, net
Other assets 2,169 2,714
Total assets $ 696,142 $ 461,318
Liabilities and
Stockholders’
Equity
Current
liabilities:
Accounts payable $ 46,389 $ 25,464
Accrued expenses
and other 126,632 89,461
current
liabilities
Derivative 2,059 1,507
liabilities
Total current 175,080 116,432
liabilities
Deferred tax 24,875 160
liability
Operating lease
liability, 12,119 13,087
long-term
Seller's 55,100 —
earn-out
Other long-term 240 97
liabilities
Total $ 267,414 $ 129,776
liabilities
Stockholders’
equity:
Common stock,
$0.01 par value;
500,000,000
shares
authorized;
65,396,253 and
64,186,549
shares issued
at September 30,
2026 and
December 31, 654 642
2025,
respectively;
57,202,356 and
57,082,173
shares
outstanding at
September 30,
2026 and
December 31,
2025,
respectively.
Additional 231,578 185,400
paid-in capital
Retained 342,956 228,014
earnings
Accumulated
other
comprehensive -1,050 486
gain
(loss)
Treasury stock,
8,193,897 shares
at cost
as of September -145,410 -83,000
30, 2026, and
7,104,376
as of December
31, 2025.
Total
stockholders’ 428,728 331,542
equity
Total
liabilities and $ 696,142 $ 461,318
stockholders’
equity
THE VITA COCO COMPANY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in thousands, except for share and per share data)
Three Nine
Months Months
Ended Ended
Septemb… Septemb…
2026 30, 2025 2026 30, 2025
──────────────────────────────────────────────────────────────────────────────
Net $ 243,825 $ 182,313 $ 639,744 $ 481,993
sales
Cost
of 151,148 113,645 369,942 303,975
goods
sold
Gross 92,677 68,668 269,802 178,018
profit
Opera…
expen…
Selli…
gener… 47,226 40,745 127,629 105,680
and
admin…
Income
from 45,451 27,923 142,173 72,338
opera…
Other
income
(expe…
Unrea…
(loss)
gain -2,083 2,391 511 6,275
on
deriv…
instr…
Forei…
curre… -887 -1,411 -2,432 -349
loss
Inter…
incom… 1,231 1,776 5,252 4,794
net
Other
(expe… -84 — -77 155
incom…
net
Total
other -1,823 2,756 3,254 10,875
(expe…
income
Income
before 43,628 30,679 145,427 83,213
income
taxes
Income
tax 8,611 6,676 30,485 17,420
expen…
Net $ 35,017 $ 24,003 $ 114,942 $ 65,793
income
Net
income
attri…
to The
Vita
Coco
Compa…
Inc.
per
common
share
Basic $ 0.61 $ 0.42 $ 2.01 $ 1.16
Dilut… $ 0.58 $ 0.40 $ 1.89 $ 1.10
Weigh…
number
of
common
shares
outst…
Basic 57,453,… 56,850… 57,274,… 56,879…
Dilut… 60,831,… 59,878… 60,786,… 59,832…
THE VITA COCO COMPANY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
Nine Months Ended
Cash flows from September 30,
operating activities: 2026 2025
──────────────────────────────────────────────────────────────────────────────
Net income $ 114,942 $ 65,793
Adjustments required
to reconcile net
income to cash flows
from operating
activities:
Depreciation and 2,458 636
amortization
Amortization of debt 14 11
issuance cost
Increase of provision 187 1,300
for credit losses
Unrealized (gain) on
derivative -511 -6,275
instruments
Stock-based 11,338 8,123
compensation
Impairment loss on — 185
Runa assets
Noncash lease expense 1,242 1,052
Changes in operating
assets and
liabilities:
Accounts receivable -42,801 -39,706
Inventory 33,259 -302
Prepaid expenses, net
supplier advances, -7,236 345
and other assets
Accounts payable,
accrued expenses, and 39,050 19,907
other liabilities
Net cash provided by
operating 151,942 51,069
activities
Cash flows from
investing activities:
Cash paid for property -803 -4,921
and equipment
Acquisition of Copra
Inc., net of $8,340 -139,253 —
cash acquired
Net cash used in -140,056 -4,921
investing activities
Cash flows from
financing activities:
Proceeds from exercise 6,131 2,281
of stock awards
Cash paid on notes -3 -8
payable
Cash paid to acquire -62,410 -10,204
treasury stock
Net cash used in -56,282 -7,931
financing activities
Effects of exchange
rate changes on cash -475 833
and cash equivalents
Net (decrease)
increase in cash and -44,871 39,050
cash
equivalents
Cash, cash equivalents
and restricted 198,154 165,933
cash at beginning of
the period (1)
Cash, cash equivalents
and restricted $ 153,283 204,983
cash at end of the
period (1)
1 Includes $1,281 and $1,264 of restricted cash as of December 31, 2025 and
2024, respectively. Includes $1,288 and $1,278 of restricted cash as of
September 30, 2026 and 2025, respectively, reported in other current assets on
the condensed consolidated balance sheet.
During the nine months ended September 30, 2026, the Company issued common stock
with a fair value of $35,000 and recognized contingent consideration with a fair
value of $55,100 in connection with the acquisition of Copra. These transactions
are reflected as noncash investing and financing activities.
RECONCILIATION FROM GAAP NET INCOME TO NON-GAAP ADJUSTED EBITDA
Three Nine
Months Months
Ended Ended
Septem… Septem…
30, 30,
2026 2026
(in (in
thousa… 2025 thousa… 2025
──────────────────────────────────────────────────────────────────────────────
Net 35,017 24,003 $ 114,9… $ 65,793
income
Depre…
and 1,493 228 2,458 636
amort…
Inter…
incom… -1,231 -1,776 -5,252 -4,794
net
Income
tax 8,611 6,676 30,485 17,420
expen…
EBITDA $ 43,890 $ 29,131 $ 142,6… $ 79,055
Stock…
compe… 3,122 2,975 11,338 8,123
(a)
Unrea…
loss
(gain)
on 2,083 -2,391 -511 -6,275
deriv…
instr…
(b)
Forei…
curre… 887 1,411 2,432 349
loss
(b)
Acqui…
costs 3,174 — 3,174 —
(c)
Other
adjus… — 1,264 — 2,886
(d)
Adjus… $ 53,156 $ 32,390 $ 159,0… $ 84,138
EBITDA
(a) Non-cash charges related to stock-based compensation, which vary from period
to period depending on volume and vesting timing of awards and forfeitures. We
adjusted for these charges to facilitate comparison from period to period.
(b) Unrealized gains or losses on derivative instruments and foreign currency
gains or losses are not considered in our evaluation of our ongoing performance.
(c) Acquisition-related costs represent transaction, advisory, legal,
accounting, valuation, and other professional fees incurred in connection with
the acquisition of Copra.
(d) The three and nine months ended September 30, 2025 included $0.6 million and
$1.8 million, respectively, related to a one-time incentive program established
in 2023 and measured based on full-year 2025 performance, and $0.4 million and
$1.1 million, respectively, of overlapping rent expense associated with our new
New York City office, and $0.2 million of impairment loss related to the sale of
Runa. The three months ended September 30, 2025 also includes $0.1 million of
provision for credit losses related to the partially recovered prepaid inventory
from a supplier recorded in the first half of 2025 (refer to the Form 10-K and
the Form 10-Q for the quarterly period ended June 30, 2025 for further details).
The nine month period was partially offset by $0.1 million of partial recoveries
of prepaid inventory from a supplier (refer to the Form 10-K for further
details) and a $0.2 million gain from a sale of intellectual property.
RECONCILIATION FROM GAAP NET SALES GROWTH TO NON-GAAP ORGANIC NET SALES GROWTH
Three Months Ended Nine Months Ended
September 30, 2026 September 30, 2026
──────────────────────────────────────────────────────────────────────────────
Net sales growth 33.7 % 32.7 %
Impact of Copra 16.0 % 6.0 %
acquisition
Organic net sales 17.8 % 26.7 %
growth
SUPPLEMENTAL INFORMATION
NET
SAL…
Thr… Nine
Mon… Mon…
(… End… End…
t… Sep… Sep…
A… 30, 30,
s… 2026 20… 2026 20…
──────────────────────────────────────────────────────────────────────────────
V…
C… $ 14… $ 132… $ 39… $ 339…
C…
W…
P… 46,… 14… 97,… 50…
L…
O… 8,7… 4,… 22,… 17…
S… $19… $1… $51… $4…
I…
s…
V…
C… $ 34,… $ 21… $ 88,… $ 54…
C…
W…
P… 10,… 8,… 30,… 19…
L…
O… 608 513 1,4… 1,…
S… $ 45,… $ 30… $ 120… $ 75…
T…
n… $ 243… $ 18… $ 639… $ 48…
s…
COST
OF
GOO…
SOLD
&
GRO…
PRO…
(… Thr… Nine
t… Mon… Mon…
C… End… End…
of Sep… Sep…
g… 30, 30,
s… 2026 20… 2026 20…
──────────────────────────────────────────────────────────────────────────────
A… $ 122… $ 93… $ 293… $ 25…
s…
I… 28,… 19… 76,… 48…
s…
T…
c…
of $ 151… $ 11… $ 369… $ 30…
g…
s…
G…
p…
A… $ 75,… $ 57… $ 225… $ 15…
s…
I… 16,… 10… 43,… 26…
s…
T…
g… $ 92,… $ 68… $ 269… $ 17…
p…
G…
m…
A… 38… % 38.1 % 43… % 37.2 %
s…
I… 37… % 35.3 % 36… % 35.4 %
s…
C… 38… % 37.7 % 42… % 36.9 %
VOLUME (CE)
Percentage
Change -
Three
Months
Ended
September
30, 2026
vs. 2025
──────────────────────────────────────────────────────────────────────────────
Americas Internati… Total
segment segment
Vita Coco
Coconut 8.5 % 50.5 % 15.8 %
Water
Private 109.9 % 23.1 % 76.7 %
Label
Other 34.9 % 108.7 % 35.8 %
Subtotal 22.5 % 42.1 % 26.5 %
Percentage
Change -
Nine Months
Ended
September
30, 2026
vs. 2025
Americas Internati… Total
segment segment
Vita Coco
Coconut 13.2 % 52.5 % 19.7 %
Water
Private 63.4 % 48.8 % 58.9 %
Label
Other 16.6 % -14.2 % 15.8 %
Subtotal 21.2 % 51.0 % 26.8 %
Note: A CE is a standard volume measure used by management which is defined as a
case of 12 bottles of 330ml liquid beverages or the same liter volume of oil. We
may have immaterial sales of raw materials at times that are treated as zero CEs
for the purposes of these calculations.